Blocking glucose reabsorption with specific SGLT2 blockers improved glucose tolerance, reduced hyperglycaemia in diabetic rats13 and reduced glomerular filtration rate (GFR), albuminuria and renal and glomerular hypertrophy in diabetic Akita mice.14 This evidence concerns the gene SLC5A2 and Hyperglycemia.